NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION (INCLUDING
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. FOR IMMEDIATE RELEASE
Sativa Group Plc
("Sativa" or the "Company" or the "Group")
CBD and Vitamin D Product Launch
24th July 2020
Sativa Group Plc [AQSE: SATI], the
The brand positioning has been strengthened with its increased product range and the additional benefits associated when combining CBD with Vitamin D.
Henry Lees-Buckley, Chief Executive Officer of Sativa, said: "A report recently commissioned by the government encourages consumers to take Vitamin D to help fight coronavirus and prepare for this winter. Our new Vitamin D product range offers an easy solution to taking CBD and Vitamin D, all in one bottle".
This is the only product range in the
This product development follows on from the Company's recently launched Goodbody website combining the two Goodbody Botanicals and Goodbody Wellness product ranges to strengthen the overall Goodbody brand. By having the one platform it will allow the brands to communicate consistently to our customers and offer the latest information within the increasing compliance requirements of the market.
The new Goodbody Wellness CBD and Vitamin D product range will appear on our Goodbody store website in the coming days at https://goodbodystore.com/
The Directors of the Company accept responsibility for the contents of this announcement.
Henry Lees-Buckley
Chief Executive Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk
Joseph Colliver
Chief Financial Officer
Sativa Group Plc
+44 (0) 20 7971 1255
enquiries@sativagroup.co.uk
www.sativagroup.co.uk
AQSE Growth Market Corporate Adviser
Guy Miller/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7220 9795
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the